siRNA therapy lowers triglycerides in clients along with unusual disorder

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran reduced triglyceride degrees by 80% and decreased the risk of pancreatitis in clients with relentless chylomicronemia, with or without a genetic medical diagnosis.